Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-22-013569

Options or other derivatives

  • Chief Medical Officer acquired 104,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Alland Leila Chief Medical Officer 2022-02-10 Grant or award · Employee Stock Option (right to buy) +104,400 104,400 D
Loading xslF345X03/doc4.xml…